Legal Update A New Era of Conundrums: Contracting with Related Pharmacies to Prepare for Gene Therapy by Elizabeth (Issie) Karan and Michael B. Glomb, Legal Counsels With the dawn of Read the full article…
Legal Update 340B Compliance Spotlight: The Importance of Self-Audits by Issie Karan, Legal Counsel Hemophilia Treatment Centers (HTCs), which participate in the 340B Discount Drug Pricing Program as Covered Entities, Read the full article…
Legal Update How to Compliantly Increase Visibility of HTCs and the Comprehensive Care Model by Elizabeth “Issie” Karan, Legal Counsel Recently, several Hemophilia Treatment Centers (HTCs) have inquired about the Read the full article…
Legal Update Really, Truly: Only Eligible Patients Can Receive 340B Drugs by Elizabeth “Issie” Karan, Legal Counsel The 340B Discount Drug Program grants eligibility to many types of federal grantees Read the full article…
Legal Update Proving the Absence of a Requirement: Use of Funds Derived from the 340B Program for Indigent Care by Elizabeth “Issie” Karan Recently, the Hemophilia Alliance team was asked Read the full article…
Legal Update Genesis Healthcare Inc. v. Becerra: Reevaluating HRSA’s Regulatory Authority for the 340B Program by Elizabeth “Issie” Karan, Legal Counsel While lawsuits related to the 340B Discount Drug Program Read the full article…
Legal Update HTCs and Chapters: Partners in Education and Outreach by Elizabeth “Issie” Karan, Legal Counsel Hemophilia Treatment Centers (HTCs) ask the Hemophilia Alliance how they can support local chapters. Read the full article…
Legal Update The Do’s and Don’ts of Contract Pharmacies in 340B Discount Drug Program for HTCs by Elizabeth “Issie” Karan, Legal Counsel The Office of Pharmacy Affairs (OPA) within the Read the full article…
Legal Update 340B Program Developments by Elizabeth “Issie” Karan, Legal Counsel On March 11, 2022, the U.S. District Court for the District of Delaware ruled that the Biden administration exceeded Read the full article…
Legal Update Grants Management that Makes Sense by Elizabeth “Issie” Karan, Legal Counsel Hemophilia Treatment Centers (HTCs) often must grapple with grey areas when it comes to compliance with the Read the full article…
